Per Stirling Capital Management, Llc. Abb Vie Inc. Transaction History
Per Stirling Capital Management, Llc.
- $705 Billion
- Q4 2024
A detailed history of Per Stirling Capital Management, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Per Stirling Capital Management, Llc. holds 9,566 shares of ABBV stock, worth $1.84 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
9,566
Previous 9,906
3.43%
Holding current value
$1.84 Million
Previous $1.96 Billion
13.11%
% of portfolio
0.24%
Previous 0.27%
Shares
9 transactions
Others Institutions Holding ABBV
# of Institutions
4,064Shares Held
1.28BCall Options Held
17.8MPut Options Held
15.7M-
Vanguard Group Inc Valley Forge, PA173MShares$33.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.98 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.65 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $341B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...